The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: 0.00 (0.00%)
Spread: 1.40 (4.375%)
Open: 32.70
High: 32.70
Low: 32.70
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

£1.5m investment into Impression Technologies

2 Jul 2015 07:00

RNS Number : 9256R
Mercia Technologies PLC
02 July 2015
 



2 July 2015

 

Mercia Technologies PLC

 

£1.5m investment into Midlands-based aluminium forming company Impression Technologies

 

Mercia Technologies PLC (AIM: MERC, "Mercia" or the "Group"), a Midlands-based investment business that specialises in building, funding and commercialising technology businesses across the UK, has committed to invest £1.5m of a £4.0m investment round into Impression Technologies Ltd, an aluminium forming company based on intellectual property developed at the University of Birmingham and Imperial College London. This investment joins investment from Imperial Innovations plc and will enable the establishment of an innovative press facility.

 

This additional capital follows a long-standing investment by the Group's third party funds managed by its wholly owned subsidiary, Mercia Fund Management ("MFM"). Following this investment, Mercia will have an 18% direct holding in Impression Technologies, and the Group will control 26% of the business when its stake via its third party funds are included.

 

Impression Technologies specialises in developing technology for forming complex, high-strength, lightweight components for the transportation industry. The Company's patented Heat treatment, Forming and in die Quenching (HFQ®) technology was developed by Impression Technologies and Imperial College, building on the founding research at the University of Birmingham. The technology allows a wide range of aluminium alloys, including ultra-high strength grades, to be formed in a fast pressing operation without compromising the strength or metallurgical properties of the material. The result is complex but lightweight components, which can be used in the manufacture of cars, trains and airplanes.

 

The proceeds will be used to fund the acquisition of a press and establishment of a press facility in collaboration with PAB Group ("PAB"), in order to continue development of the technology, and to effectively keep up with volume demand. PAB is currently supplying parts, made with HFQ technology, to the motor industry.

 

Mark Payton, Chief Executive of Mercia Technologies PLC, said:

 

"We are proud to continue to support this innovative company, which is located in the Midlands, the heart of the UK manufacturing space for the automotive and aerospace sectors, and based in part on technology from one of our partners, the University of Birmingham.

 

"The addition of a high speed press facility is crucial in enabling the Company to both demonstrate its patented Hot Form Quench technology and service the high level of commercial interest which has already been expressed by key players in the motor and aerospace industries.

 

"Impression Technologies provides a demonstration of our regional emphasis and our focus on UK technology sectors that offer investment prospects with high growth potential, including advanced materials, engineering and specialised manufacturing."

 

For further information contact:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Martin Glanfield, Chief Financial Officer

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu (Nomad) / Mark Connelly

Instinctif Partners

+44 (0) 20 7457 2020

Kay Larsen / Lauren Foster

 

Notes to editors

 

Mercia Technologies PLC 

Mercia creates, funds and develops technology businesses nationally with an emphasis in the Midlands, the North and Scotland. It brings technology transfer, company formation, incubation, commercialisation and investment, to technology ventures. Approximately 50% of its investments derive from university spinouts. Mercia invests across key technology sectors in which it has deep sector expertise in.

 

The Mercia model is one of patiently nurturing businesses through its third party funds under management, and then scaling them with direct investment at the point of commercial delivery. Through this, Mercia has a well seeded portfolio and pipeline of investments - its 'emerging stars'. The Group has a direct investment in 15 operating companies and access to a portfolio of circa 44 businesses through its third party funds, managed by its wholly owned subsidiary Mercia Fund Management.

 

Mercia's shares started trading on AIM on 18 December 2014, since then Mercia has invested approximately £13m directly across its portfolio of emerging stars which in themselves have attracted a total investment of over £70m alongside investment from the Group to date. In addition to its direct investments, Mercia (via Mercia Fund Management) has invested over £19m to build its portfolio of potential emerging stars.

 

Impression Technologies Ltd

Impression Technologies provides advanced high-temperature metal forming technologies that enable cost-effective lightweight components to be realised. The technology was jointly developed at the University of Birmingham and Imperial College London by Professor Dean and Professor Lin, respectively. The Company offers Licensing, Training and Support services for forming processes, forming simulation and material test methods. Its portfolio of patented technologies includes the HFQ method, used to form complex components from high-strength sheet aluminium.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVRDIILIIE
Date   Source Headline
20th Dec 201910:29 amRNSResult of General Meeting
9th Dec 20192:05 pmRNSSecond Price Monitoring Extn
9th Dec 20192:00 pmRNSPrice Monitoring Extension
5th Dec 20197:00 amRNSPosting of documents and Notice of GM
3rd Dec 20193:46 pmRNSResult of Accelerated Bookbuild to raise £30.0m
3rd Dec 20199:05 amRNSSecond Price Monitoring Extn
3rd Dec 20199:00 amRNSPrice Monitoring Extension
3rd Dec 20197:01 amRNSProposed Acquisition & ABB to raise £30.0million
3rd Dec 20197:00 amRNSHalf Year Results
20th Nov 20197:00 amRNSnDreams makes significant commercial progress
14th Nov 20197:00 amRNSAppointment of Joint Broker
5th Nov 201911:02 amRNSNotification of Major Holdings
4th Nov 20194:49 pmRNSNotification of Major Holdings
1st Nov 20194:31 pmRNSNotification of Major Holdings
22nd Oct 20194:54 pmRNSNotification of Major Holdings
17th Oct 20191:59 pmRNSNotification of Major Holdings
16th Oct 20197:36 amRNSNotification of Major Holdings
25th Sep 20197:00 amRNSAnnouncement of significant contract for OXGENE
24th Sep 201911:02 amRNSResult of AGM
24th Sep 20197:00 amRNSAGM Statement
10th Sep 20197:00 amRNS£7.5million syndicated investment into Voxpopme
1st Aug 20197:00 amRNSGrant of Options
29th Jul 20192:24 pmRNSNotification of Major Holdings
26th Jul 20197:00 amRNSPublication of Annual Report
8th Jul 20197:00 amRNSPreliminary Results
5th Jul 201910:00 amRNSChange of Name
2nd Jul 20197:00 amRNSDirectorate Change
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.